Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States.

Allen D DaoVy H NguyenTakanori ItoRamsey CheungMindie H Nguyen

Published in: Hepatology international (2022)

Nonobese MAFLD constitutes about half of the MAFLD in the United States, especially among males and the elderly. Notably, nonobese MAFLD carries higher mortality than obese MAFLD. Screening and diagnosis of MAFLD should be considered in nonobese populations.

Keyphrases

risk factors
adipose tissue
metabolic syndrome
cardiovascular events
weight loss
type diabetes
obese patients
cardiovascular disease
coronary artery disease
middle aged
community dwelling